Bausch Lobs IP Suit At Mylan Over Planned Trulance Generic
Bausch has hit Mylan Laboratories Ltd., Agila Specialties Inc. and Viatris Inc. with a suit in Delaware federal court accusing the companies of infringing eight patents on its gastrointestinal medicine Trulance...To view the full article, register now.
Already a subscriber? Click here to view full article